Get startedLog in
    Picture of Zealand Pharma A/S logo

    ZEAL — Zealand Pharma A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapNeutral
    All News

    Brief: Zealand Pharma Enters Into A USD 100 Million Royalty Purchase And Sale Agreement With Royalty Pharma

    Picture of Zealand Pharma A/S logoZealand Pharma A/S
    12/08/2026 22:17
    BRIEF-Zealand Pharma Enters Into A USD 100 Million Royalty Purchase And Sale Agreement With Royalty Pharma 
    Aug 12 (Reuters) - Zealand Pharma A/S ZELA.CO:
    • ZEALAND PHARMA ENTERS INTO A USD 100 MILLION ROYALTY PURCHASE AND SALE AGREEMENT WITH ROYALTY PHARMA FOR THE ECONOMICS RELATED TO RUSFERTIDE
    • ZEALAND PHARMA: TO RECEIVE $50 MILLION UPFRONT, $50 MILLION IN ONE YEAR FROM ROYALTY PHARMA DEAL
    • ZEALAND PHARMA: CO TO RETAIN 0.25%, ROYALTY PHARMA TO RETAIN 0.75% ROYALTY ON ANNUAL NET GLOBAL SALES OF RUSFERTIDE OVER $1.5 BILLION
    • ZEALAND PHARMA: FDA HAS SET PDUFA DATE FOR RUSFERTIDE NDA IN Q3 2026
    Source text: ID:nGNX5MqCcM
    Further company coverage: ZELA.CO

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Zealand Pharma A/S

    See all news